Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,24920,662,2.12 [1.60-2.82],2.1766625912371377e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24962,663,1.63 [1.33-1.99],1.761671715824277e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,25174,662,1.51 [1.23-1.85],9.435767515762607e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,24962,663,1.64 [1.30-2.05],2.2467795332169484e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21689,568,1.43 [1.25-1.64],1.5605262669167185e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21810,572,1.35 [1.17-1.56],6.123353665188289e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BSG,Basigin,25371,665,2.15 [1.49-3.10],4.5672383314286845e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,25213,664,1.82 [1.39-2.38],1.1599888640072526e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,24995,659,1.59 [1.26-2.01],8.840039667412747e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,24158,623,1.85 [1.37-2.51],6.639960024972171e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,25354,664,1.49 [1.22-1.81],8.121516833608585e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,25354,664,1.63 [1.35-1.97],3.841095048947225e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,25280,662,1.78 [1.40-2.28],3.810935089718116e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,25340,666,2.12 [1.53-2.95],7.119820557061186e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,25213,664,1.67 [1.29-2.16],8.39625627225048e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,24962,663,1.52 [1.24-1.85],4.101974297010651e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,25414,666,1.28 [1.13-1.44],8.925364453873247e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,25169,666,1.81 [1.43-2.29],9.303112355021284e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21689,568,1.66 [1.32-2.09],1.2333937435298113e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,25064,662,1.79 [1.39-2.30],5.769235560961751e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24920,662,2.11 [1.67-2.66],3.246977765687954e-10
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,25414,666,1.89 [1.44-2.49],4.86302382025144e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24915,663,1.94 [1.55-2.43],8.837634678496833e-09
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,25414,666,1.57 [1.28-1.94],2.2498429917953448e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,25094,656,1.71 [1.35-2.17],9.348916107161111e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,25048,664,1.67 [1.31-2.13],4.09506384510708e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,25053,659,1.77 [1.42-2.22],5.160884670222885e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,25414,666,1.37 [1.19-1.59],2.1632512145887327e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,25109,663,1.60 [1.31-1.95],2.84113971206148e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25100,655,1.67 [1.32-2.11],1.825658541424566e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,25414,666,2.06 [1.51-2.83],6.339243278265246e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,24775,649,1.73 [1.47-2.02],1.3293989892681887e-11
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25089,660,1.57 [1.30-1.88],1.9837564282063257e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24915,663,1.67 [1.36-2.06],9.63702520785534e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,21748,568,1.47 [1.22-1.76],4.357941485539074e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24945,655,1.83 [1.43-2.35],1.5473744797500598e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,25169,666,1.78 [1.36-2.31],1.9122879573827083e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,25094,656,1.82 [1.43-2.32],1.0132381363865976e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,25169,666,1.64 [1.32-2.05],1.0668575502961254e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,25122,656,1.61 [1.30-1.99],1.029740625093724e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",OGN,Mimecan,25109,663,1.43 [1.21-1.70],3.691320269804696e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,25421,667,1.79 [1.44-2.23],1.372024796661449e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25109,663,2.03 [1.57-2.61],4.3332925070228905e-08
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,21176,550,1.57 [1.26-1.95],5.974688281004188e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24900,656,1.81 [1.46-2.25],6.038005248025396e-08
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24872,663,1.60 [1.29-1.99],1.969862603968007e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,25109,663,1.99 [1.56-2.55],4.492481054018847e-08
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,25354,664,1.85 [1.42-2.41],4.233514871559142e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,25289,661,1.74 [1.36-2.23],9.854731572618129e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,24484,652,1.95 [1.56-2.45],7.201247100454018e-09
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,21185,560,1.73 [1.36-2.21],9.060977884424963e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,25074,660,1.29 [1.14-1.46],3.261981283401033e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,25169,666,1.78 [1.43-2.20],1.2686130694925e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,25122,656,1.74 [1.36-2.22],1.263816566207367e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,25340,666,1.93 [1.56-2.39],1.6903324420723662e-09
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25109,663,1.82 [1.43-2.31],9.010681218578692e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25109,663,1.39 [1.20-1.60],7.653589568707893e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24962,663,1.49 [1.26-1.76],4.057107500066586e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,24962,663,1.55 [1.29-1.87],3.856995465064673e-06
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,25069,661,1.60 [1.34-1.91],1.5908106210641156e-07
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",VWC2,Brorin,24873,662,1.44 [1.20-1.73],7.516976133393803e-05
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23800,632,1.65 [1.37-1.99],1.7312877546048834e-07
